[1. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387(10023):1109–22.10.1016/S0140-6736(15)00149-X]Search in Google Scholar
[2. Lara-Corrales I, Huang CM, Parkin PC, Rubio-Gomez GA, Posso-De Los Rios CJ, Maguire J, et al. Vitamin D Level and Supplementation in Pediatric Atopic Dermatitis: A Randomized Controlled Trial. J Cutan Med Surg; 2018.10.1177/120347541880574430336685]Search in Google Scholar
[3. Diluvio L, Dattola A, Cannizzaro MV, Franceschini C, Bianchi L. Clinical and confocal evaluation of avenanthramides-based daily cleansing and emollient cream in pediatric population affected by atopic dermatitis and xerosis. G Ital di Dermatologia e Venereol. 2019;154(1):32–6.10.23736/S0392-0488.18.06002-930207438]Search in Google Scholar
[4. Yan DC, Hung CH, Sy LB, Lue KH, Shih IH, Yang CY, et al. A randomized, double-blind, placebo-controlled trial assessing the oral administration of a heat-treated lactobacillus paracasei supplement in infants with atopic dermatitis receiving topical corticosteroid therapy. Skin Pharmacol Physiol. 2019;32(4):201–11.10.1159/00049943631117100]Search in Google Scholar
[5. Lisante TA, Nuñez C, Zhang P. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study. J Dermatolog Treat. 2017;28(7):659–67.10.1080/09546634.2017.130356928366039]Search in Google Scholar
[6. Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL, et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis Work Group. J Am Acad Dermatol. 2014;70(2):338–51..10.1016/j.jaad.2013.10.010441018324290431]Search in Google Scholar
[7. Abbasi S, Kamalinejad M, Babaie D, Shams SM, Sadr Z, Gheysari M, et al. A new topical treatment of atopic dermatitis in pediatric patients based on Ficus carica L. (Fig): A randomized, placebo-controlled clinical trial. Complement Ther Med. 2017;35(August):85–91.10.1016/j.ctim.2017.10.00329154073]Search in Google Scholar
[8. Stettler H, Kurka P, Kandzora J, Pavel V, Breuer M, Macura-Biegun A. A new topical panthenol-containing emollient for maintenance treatment of childhood atopic dermatitis: results from a multicenter prospective study. J Dermatolog Treat. 2017;28(8):774–9.10.1080/09546634.2017.132893828511614]Search in Google Scholar
[9. Wolter S, Price HN. Atopic Dermatitis. Pediatr Clin North Am [Internet]. 2014;61(2):241–60. Available from: http://dx.doi.org/10.1016/j.pcl.2013.11.00210.1016/j.pcl.2013.11.00224636644]Search in Google Scholar
[10. Taghavi Ardakani A, Farrehi M, Sharif MR, Ostadmohammadi V, Mirhosseini N, Kheirkhah D, et al. The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial. Pediatr Allergy Immunol. 2018;29(8):834–40.10.1111/pai.1297830160043]Search in Google Scholar
[11. Lee SC. Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire-based diagnostic tool for AD. J Dermatol. 2016;43(4):376–84.10.1111/1346-8138.1326426813749]Search in Google Scholar
[12. Chan S, Cornelius V, Chen T, Radulovic S, Wan M, Jahan R, et al. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): The role of anti-IgE in severe paediatric eczema: Study protocol for a randomised controlled trial. Trials. 2017;18(1):1–7.10.1186/s13063-017-1809-7536170428330497]Search in Google Scholar
[13. Licari A, Ruffinazzi G, De Filippo M, CastaGnoli R, Marseglia A, Agostinis F, et al. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: A three-center, assessor blinded trial. Minerva Pediatr. 2017;69(6):470–5.10.23736/S0026-4946.17.05015-029181960]Search in Google Scholar
[14. Chang Y Sen, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, et al. Melatonin Supplementation for Children with Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42.10.1001/jamapediatrics.2015.309226569624]Search in Google Scholar
[15. Heeney DD, Gareau MG, Marco ML. Intestinal Lactobacillus in health and disease, a driver or just along for the ride? Curr Opin Biotechnol. 2018;49:140–7.]Search in Google Scholar
[16. 1Zhang Z, Lv J, Pan L, Zhang Y. Roles and applications of probiotic Lactobacillus strains. Appl Microbiol Biotechnol. 2018;102(19):8135–43.10.1007/s00253-018-9217-930032432]Search in Google Scholar
[17. Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015;45(4):779–87.10.1111/cea.1248925600169]Search in Google Scholar
[18. Wu YJ, Wu WF, Hung CW, Ku MS, Liao PF, Sun HL, et al. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4–48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study. J Microbiol Immunol Infect. 2017;50(5):684–92.10.1016/j.jmii.2015.10.00326733351]Search in Google Scholar
[19. Kwon SH, Lim CJ, Jung J, Kim HJ, Park K, Shin JW, et al. The effect of autophagy-enhancing peptide in moisturizer on atopic dermatitis: a randomized controlled trial. J Dermatolog Treat. 2019;30(6):558–64.10.1080/09546634.2018.154440730427231]Search in Google Scholar
[20. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of. Gut [Internet]. 2003;52:827–34.10.1136/gut.52.6.827177368712740338]Search in Google Scholar
[21. Navarro-Lopez V, Ramirez-Bosca A, Ramon-Vidal D, Ruzafa-Costas B, Genoves-Martinez S, Chenoll-Cuadros E, et al. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis a randomized clinical trial. JAMA Dermatology. 2018;154(1):37–43.10.1001/jamadermatol.2017.3647583358229117309]Search in Google Scholar
[22. Zane LT, Kircik L, Call R, Tschen E, Draelos ZD, Chanda S, et al. Crisaborole topical ointment, 2% in patients ages 2 to 17 years with atopic dermatitis: A phase 1b, open-label, maximal-use systemic exposure study. Pediatr Dermatol. 2016;33(4):380–7.10.1111/pde.12872508476127193740]Search in Google Scholar
[23. Cadmus SD, Sebastian KR, Warren D, Hovinga CA, Croce EA, Reveles LA, et al. Efficacy and patient opinion of wet-wrap dressings using 0.1% triamcinolone acetonide ointment vs cream in the treatment of pediatric atopic dermatitis: A randomized split-body control study. Pediatr Dermatol. 2019;36(4):437–41.]Search in Google Scholar
[24. Chan S, Cornelius V, Cro S, Harper JI, Lack G. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial. JAMA Pediatr. 2020;174(1):29–37.10.1001/jamapediatrics.2019.4476690211231764962]Search in Google Scholar
[25. Simpson EL, Paller AS, Siegfried EC, Boguniewicz M, Sher L, Gooderham MJ, et al. Efficacy and Safety of Dupilumab in Adolescents with Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial. JAMA Dermatology. 2020;156(1):44–56.10.1001/jamadermatol.2019.3336686526531693077]Search in Google Scholar